0001562180-17-002433.txt : 20170706
0001562180-17-002433.hdr.sgml : 20170706
20170706122351
ACCESSION NUMBER: 0001562180-17-002433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170703
FILED AS OF DATE: 20170706
DATE AS OF CHANGE: 20170706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nash Duane
CENTRAL INDEX KEY: 0001591098
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 17951443
MAIL ADDRESS:
STREET 1: C/O VITAL THERAPIES, INC.
STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-07-03
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001591098
Nash Duane
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2017-07-03
4
S
false
990.00
14.27
D
23687.00
D
Shares sold by reporting person pursuant to a 10b5-1 plan to pay taxes in connection with the vesting of restricted stock pursuant to the December 23, 2013 award.
Nicole R. Hadas, Attorney-in-Fact for Duane Nash
2017-07-06